+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Smart Biopsy Market (2019-2025)

  • ID: 4871831
  • Report
  • November 2019
  • Region: Asia Pacific
  • 90 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Medtronic Plc.
  • Olympus Corporation
The Asia Pacific Smart Biopsy Market is expected to witness market growth of 6.58% CAGR during the forecast period (2019-2025).

According to the World Cancer Report, there will be 15 million additional cases of cancer by the end of 2020. The worldwide pervasiveness of cancer diseases like lung cancer, breast cancer, prostate cancer, etc., is expected to drive the market scenario. People are more health-conscious these days and switch to minimally invasive techniques over traditional techniques in order to ensure complete security.

Current diagnostic tools for cancer involve invasive procedures like biopsies. However, if the lesion was better defined, such painful procedures could be avoided in many cases. In addition, the increased costs of these invasive biopsies and their association with painful procedures often put patients in a position of avoiding or delaying the procedure. This leads to an insufficient diagnosis of people or diagnosis of patients at a later stage of the disease.

The Asia- Pacific region is anticipated to experience the highest growth rate over the forecast period. This rapid growth rate can be attributed to extensive government initiatives, healthcare spending, cancer awareness campaigns, and the availability of technologically advanced smart biopsy devices. The Indian Government has announced two major initiatives in the healthcare sector, namely the Ayushman Bharat Program and the National Health Protection Scheme.

Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.

Scope of the Study

Market Segmentation:

By Application
  • Breast cancer
  • Skin cancer
  • Liver cancer
  • Prostate cancer and
  • Others

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled
  • Danaher Corporation
  • Argon Medical Devices, Inc.
  • Cardinal Health, Inc.
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Boston Scientific Corporation
  • Olympus Corporation
  • Hologic, Inc.
  • B. Braun Melsungen AG
  • Cook Medical, Inc. (Cook Group)
  • Medtronic Plc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Medtronic Plc.
  • Olympus Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Smart Biopsy Market, by Application
1.4.2 Asia Pacific Smart Biopsy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Market Analysis
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers : 2019-Nov - 2016-May) Leading Players
Chapter 4. Asia Pacific Smart Biopsy Market by Application
4.1 Asia Pacific Breast cancer Market by Country
4.2 Asia Pacific Skin cancer Market by Country
4.3 Asia Pacific Liver cancer Market by Country
4.4 Asia Pacific Prostate cancer Market by Country
4.5 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Smart Biopsy Market by Country
5.1 China Smart Biopsy Market
5.1.1 China Smart Biopsy Market by Application
5.2 India Smart Biopsy Market
5.2.1 India Smart Biopsy Market by Application
5.3 Japan Smart Biopsy Market
5.3.1 Japan Smart Biopsy Market by Application
5.4 South Korea Smart Biopsy Market
5.4.1 South Korea Smart Biopsy Market by Application
5.5 Singapore Smart Biopsy Market
5.5.1 Singapore Smart Biopsy Market by Application
5.6 Malaysia Smart Biopsy Market
5.6.1 Malaysia Smart Biopsy Market by Application
5.7 Rest of Asia Pacific Smart Biopsy Market
5.7.1 Rest of Asia Pacific Smart Biopsy Market by Application
Chapter 6. Company Profiles
6.1 Danaher Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments
6.1.5.1 Product Launches
6.1.5.2 Acquisition and Mergers
6.1.6 SWOT Analysis
6.2 Argon Medical Devices, Inc.
6.2.1 Company Overview
6.2.1 Recent strategies and developments
6.2.1.1 Partnerships, Collaborations, and Agreements
6.2.1.2 Acquisition and Mergers
6.3 Cardinal Health, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments
6.3.4.1 Acquisition and Mergers
6.4 Canon, Inc. (Canon Medical Systems Corporation)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments
6.4.5.1 Product Launches
6.4.5.2 Acquisition and Mergers
6.4.5.3 Expansions
6.4.6 SWOT Analysis
6.5 Boston Scientific Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments
6.5.5.1 Product Launches
6.5.5.2 Acquisition and Mergers
6.5.5.3 Expansions
6.5.6 SWOT Analysis
6.6 Olympus Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments
6.6.5.1 Partnerships, Collaborations, and Agreements
6.6.5.2 Acquisition and Mergers
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments
6.7.5.1 Product Launches
6.7.5.2 Partnerships, Collaborations, and Agreements
6.7.5.3 Acquisition and Mergers
6.7.6 SWOT Analysis
6.8 B. Braun Melsungen AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Cook Medical, Inc. (Cook Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments
6.9.2.1 Product Launches
6.1 Medtronic PLC
6.10.1 Company overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expenses
6.10.5 Recent strategies and developments
6.10.5.1 Product Launches
6.10.5.2 Acquisition and Mergers
6.10.6 SWOT Analysis
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Danaher Corporation
  • Argon Medical Devices, Inc.
  • Cardinal Health, Inc.
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Boston Scientific Corporation
  • Olympus Corporation
  • Hologic, Inc.
  • B. Braun Melsungen AG
  • Cook Medical, Inc. (Cook Group)
  • Medtronic Plc.
Note: Product cover images may vary from those shown

Loading
LOADING...